Home  /  Middle East and North Africa  /  YEM

Yemen

Yemen appears only through international and donor bodies that compile figures across many countries, and no figures for the country are read directly from a national publisher. The assessment of national sources, country by country, is set out on the Methods page.

15,000
People living with HIV, 2025
WHO Global Health Observatory
34.0%
On antiretroviral treatment, 2025
WHO Global Health Observatory
$50k
United States HIV disbursements, 2013
OECD Creditor Reporting System
$528
External HIV financing, all donors, 2021
OECD Creditor Reporting System
External HIV financing
OECD CRS · ForeignAssistance.gov
$0$2m$4m2003200520072009201120132015201720192021$528$50k$54k$50k
  • All donors
  • United States, OECD record
  • The Global Fund
  • United States, self-reported
YearAll donorsUnited States, OECD recordThe Global FundUnited States, self-reported
2003 $215k — — —
2004 $433k — — —
2005 $2.9m — $2.4m —
2006 $1.3m — $982k —
2007 $1.1m — $514k —
2008 $3.1m — $2.2m —
2009 $558k $34k — $34k
2010 $5.4m $6k $4.6m $6k
2011 $282k — — —
2012 $601k — $322k —
2013 $934k $50k $496k $50k
2014 $607k — $218k —
2015 $627k — $445k —
2016 $397k — $258k —
2017 $206k — $54k —
2018 $22k — — —
2019 $20k — — —
2020 $77k — — —
2021 $528 — — —

19 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Disbursements reported for the country. The OECD record and the United States self-reported record are drawn separately. The two records cover the same United States disbursements, but the OECD record is filed by calendar year and the self-reported record by United States fiscal year.

People living with HIV and people on treatment
UNAIDS AIDSinfo
05k10k15k20002003200620092012201520182021202416,0004,600
  • People living with HIV
  • People on treatment
YearPeople living with HIVPeople living with HIV (lower)People living with HIV (upper)People on treatment
2000 1,600 1,500 1,700 —
2001 1,900 1,800 2,000 —
2002 2,200 2,100 2,400 —
2003 2,600 2,400 2,800 —
2004 3,100 2,800 3,300 —
2005 3,700 3,300 3,900 —
2006 4,300 3,900 4,600 —
2007 5,000 4,500 5,300 —
2008 5,800 5,300 6,100 —
2009 6,500 6,000 6,900 —
2010 7,000 6,500 7,500 500
2011 7,400 7,000 7,900 630
2012 7,800 7,300 8,300 720
2013 8,200 7,700 8,600 900
2014 8,700 8,200 9,100 1,200
2015 9,200 8,700 9,600 1,400
2016 9,800 9,300 10,000 1,800
2017 11,000 9,900 11,000 2,000
2018 11,000 10,000 12,000 2,300
2019 12,000 11,000 13,000 2,700
2020 13,000 12,000 14,000 2,900
2021 13,000 12,000 15,000 3,200
2022 14,000 13,000 16,000 3,600
2023 15,000 14,000 17,000 4,100
2024 16,000 14,000 18,000 4,600

25 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Modelled estimates. The shaded area is the published uncertainty interval around the number of people living with HIV, because a single estimate without the interval would overstate the precision of the model.

The treatment cascade
UNAIDS AIDSinfo
0%10%20%30%40%2010201220142016201820202022202440.0%29.0%
  • Diagnosed
  • On treatment
YearDiagnosedOn treatment
2010 30.0% 7.0%
2011 31.0% 8.0%
2012 32.0% 9.0%
2013 34.0% 11.0%
2014 36.0% 14.0%
2015 36.0% 15.0%
2016 37.0% 18.0%
2017 37.0% 19.0%
2018 37.0% 21.0%
2019 38.0% 22.0%
2020 37.0% 23.0%
2021 38.0% 24.0%
2022 38.0% 26.0%
2023 39.0% 27.0%
2024 40.0% 29.0%

15 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Every line is a percentage of all people living with HIV, so the three lines share a denominator and can be compared directly. Viral suppression in the figure is the share of all people living with HIV who are virally suppressed, and not the narrower third 95 target, which counts only people on treatment.

Sources of the figures for Yemen

2,624 rows

SourceTypeRowsIndicators YearsRead fromRetrieved
UNICEF HIV/AIDS dataset Modelled estimate 1,375 5 2010–2025 sdmx.data.unicef.org 2026-10-20
UNAIDS AIDSinfo Modelled estimate 740 19 2000–2024 aidsinfo.unaids.org 2026-10-20
WHO Global Health Observatory Modelled estimate 226 10 2000–2025 ghoapi.azureedge.net 2026-10-12
WHO Global Tuberculosis Programme Programme record 155 16 2000–2025 extranet.who.int 2026-10-16
World Bank Open Data Modelled estimate 51 2 2000–2025 api.worldbank.org 2026-10-12
IATI, through d-portal Expenditure account 38 3 2003–2026 d-portal.org 2026-10-12
OECD Creditor Reporting System Expenditure account 33 3 2003–2021 sdmx.oecd.org 2026-10-12
ForeignAssistance.gov Expenditure account 6 2 2009–2013 foreignassistance.gov 2026-10-29

Indicators held

42 of 150

IndicatorDomainUnitRows YearsSourcesMost recent value
Actual expenditure on collaborative TB/HIV activities Financing USD 8 2017–2024 WHO Global Tuberculosis Programme $14k (2024)
Budget required for collaborative TB/HIV activities Financing USD 8 2018–2025 WHO Global Tuberculosis Programme $14k (2025)
Domestic funding received by the national TB programme Financing USD 8 2017–2024 WHO Global Tuberculosis Programme $15k (2024)
Expected Global Fund funding for the national TB programme Financing USD 8 2018–2025 WHO Global Tuberculosis Programme $2.1m (2025)
Expected USAID funding for the national TB programme Financing USD 7 2019–2025 WHO Global Tuberculosis Programme $0 (2025)
Expected domestic funding for the national TB programme Financing USD 8 2018–2025 WHO Global Tuberculosis Programme $15k (2025)
Expected funding for collaborative TB/HIV activities Financing USD 8 2018–2025 WHO Global Tuberculosis Programme $4k (2025)
External HIV financing (all donors, ODA) Financing USD 19 2003–2021 OECD Creditor Reporting System $528 (2021)
External HIV financing from governments other than the United States (IATI) Financing USD 14 2003–2023 IATI, through d-portal $0 (2023)
External HIV financing from multilateral bodies other than the Global Fund (IATI) Financing USD 12 2015–2026 IATI, through d-portal $51k (2026)
External HIV financing from the United States (ODA) Financing USD 6 2009–2013 ForeignAssistance.gov, OECD Creditor Reporting System $50k (2013)
Funding received for collaborative TB/HIV activities Financing USD 8 2017–2024 WHO Global Tuberculosis Programme $14k (2024)
Global Fund HIV disbursements to the country Financing USD 23 2005–2017 IATI, through d-portal, OECD Creditor Reporting System $54k (2017)
Global Fund funding received by the national TB programme Financing USD 8 2017–2024 WHO Global Tuberculosis Programme $1.9m (2024)
US HIV disbursements managed by other US agencies Financing USD 3 2009–2013 ForeignAssistance.gov $50k (2013)
USAID funding received by the national TB programme Financing USD 7 2017–2024 WHO Global Tuberculosis Programme $0 (2024)
% of ALL PLHIV who are virally suppressed Treatment cascade percent 1 2025 WHO Global Health Observatory 30.0% (2025)
% of PLHIV on ART (second 95, PLHIV base) Treatment cascade percent 67 2000–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 34.0% (2025)
% of PLHIV who have been diagnosed (first 95) Treatment cascade percent 26 2010–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 43.0% (2025)
% of estimated HIV-positive incident TB cases on TB treatment and ART Treatment cascade percent 14 2005–2024 UNAIDS AIDSinfo 0.1% (2024)
% of people newly enrolled in HIV treatment diagnosed with TB disease Treatment cascade percent 1 2013 UNAIDS AIDSinfo 7.3% (2013)
% of people on ART who are virally suppressed (third 95) Treatment cascade percent 1 2025 WHO Global Health Observatory 89.0% (2025)
HIV-exposed infants tested within two months of birth Treatment cascade percent 5 2010–2014 UNAIDS AIDSinfo 2.0% (2014)
HIV-positive TB patients started or continued on ART Treatment cascade count 6 2015–2024 WHO Global Tuberculosis Programme 0 (2024)
Number of people on ART (PEPFAR MER TX_CURR) Treatment cascade count 67 2000–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 5,078 (2025)
PMTCT ART coverage among pregnant women with HIV Treatment cascade percent 29 2010–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset 14.0% (2025)
People newly enrolled on ART during the year Treatment cascade count 1 2013 WHO Global Tuberculosis Programme 372 (2013)
Pregnant women tested for HIV in antenatal care Treatment cascade percent 12 2010–2024 UNAIDS AIDSinfo 77.0% (2024)
Pregnant women with HIV who received ARVs for PMTCT Treatment cascade count 30 2010–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 51 (2025)
TB patients recorded as HIV-positive Treatment cascade count 10 2015–2024 WHO Global Tuberculosis Programme 39 (2024)
TB patients with an HIV test result recorded Treatment cascade count 10 2015–2024 WHO Global Tuberculosis Programme 4,693 (2024)
AIDS-related deaths Epidemic estimates count 681 2000–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory 590 (2025)
Deaths from TB among people living with HIV Epidemic estimates count 50 2000–2024 UNAIDS AIDSinfo, WHO Global Tuberculosis Programme 31 (2024)
HIV prevalence among a key population Epidemic estimates percent 2 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
HIV prevalence, ages 15-49 Epidemic estimates percent 50 2000–2024 UNAIDS AIDSinfo, World Bank Open Data 0.1% (2024)
Incident TB cases among people living with HIV Epidemic estimates count 50 2000–2024 UNAIDS AIDSinfo, WHO Global Tuberculosis Programme 120 (2024)
New HIV infections Epidemic estimates count 585 2000–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory 1,200 (2025)
People living with HIV Epidemic estimates count 681 2000–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory 15,000 (2025)
Estimated pregnant women with HIV needing ARVs for PMTCT Population denominators count 31 2010–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 500 (2025)
Estimated size of a key population Population denominators count 2 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
Total population Population denominators count 26 2000–2025 World Bank Open Data 41,773,878 (2025)
Share of HIV-exposed infants who acquire HIV — percent 31 2010–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset 37.8% (2025)

Every row shown on the Yemen page is in the panel download, with the source URL and the retrieval date of the row attached. See Data.